The critical Hb level threshold below which DO2 becomes significantly impaired and transfusion becomes less harmful than persisting anemia is unknown and likely varies depending upon the underlying condition and clinical status of each patient. This evidence concerns the gene GSTM1 and anemia (phenotype).